Causal inference in survival analysis using longitudinal observational data: Sequential trials and marginal structural models

被引:11
|
作者
Keogh, Ruth H. [1 ,2 ,7 ]
Gran, Jon Michael [3 ]
Seaman, Shaun R. [4 ]
Davies, Gwyneth [5 ]
Vansteelandt, Stijn [1 ,2 ,6 ]
机构
[1] London Sch Hyg & Trop Med, Dept Med Stat, Keppel St, London WC1E 7HT, England
[2] Ctr Stat Methodol, London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England
[3] Univ Oslo, Inst Basic Med Sci, Oslo Ctr Biostat & Epidemiol, Dept Biostat, POB 1122 Blindern, N-0317 Oslo, Norway
[4] Univ Cambridge, MRC Biostat Unit, East Forvie Bldg,Forvie Site,Robinson Way, Cambridge CB2 0SR, England
[5] UCL, UCL Great Ormond St Inst Child Hlth, Populat Policy & Practice Res & Teaching Dept, London WC1N 1EH, England
[6] Univ Ghent, Dept Appl Math Comp Sci & Stat, B-9000 Ghent, Belgium
[7] London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England
基金
英国科研创新办公室; 英国医学研究理事会;
关键词
cystic fibrosis; inverse probability weighting; marginal structural model; registries; sequential trials; survival; target trials; time-dependent confounding; TARGET TRIAL; COX APPROACH; TIME; MORTALITY; REGRESSION; EMULATION; PREDICTOR; RISK; UK;
D O I
10.1002/sim.9718
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Longitudinal observational data on patients can be used to investigate causal effects of time-varying treatments on time-to-event outcomes. Several methods have been developed for estimating such effects by controlling for the time-dependent confounding that typically occurs. The most commonly used is marginal structural models (MSM) estimated using inverse probability of treatment weights (IPTW) (MSM-IPTW). An alternative, the sequential trials approach, is increasingly popular, and involves creating a sequence of "trials" from new time origins and comparing treatment initiators and non-initiators. Individuals are censored when they deviate from their treatment assignment at the start of each "trial" (initiator or noninitiator), which is accounted for using inverse probability of censoring weights. The analysis uses data combined across trials. We show that the sequential trials approach can estimate the parameters of a particular MSM. The causal estimand that we focus on is the marginal risk difference between the sustained treatment strategies of "always treat" vs "never treat." We compare how the sequential trials approach and MSM-IPTW estimate this estimand, and discuss their assumptions and how data are used differently. The performance of the two approaches is compared in a simulation study. The sequential trials approach, which tends to involve less extreme weights than MSM-IPTW, results in greater efficiency for estimating the marginal risk difference at most follow-up times, but this can, in certain scenarios, be reversed at later time points and relies on modelling assumptions. We apply the methods to longitudinal observational data from the UK Cystic Fibrosis Registry to estimate the effect of dornase alfa on survival.
引用
收藏
页码:2191 / 2225
页数:35
相关论文
共 50 条